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Sleep disorders in cerebellar ataxias
José L. Pedroso, Pedro Braga-Neto, André C. Felício,  
Camila C.H. Aquino, Lucila B. Fernandes do Prado,  
Gilmar Fernandes do Prado, Orlando G.P. Barsottini
ABSTRACT
Cerebellar ataxias comprise a wide range of etiologies leading to central nervous 
system-related motor and non-motor symptoms. Recently, a large body of evidence 
has demonstrated a high frequency of non-motor manifestations in cerebellar ataxias, 
specially in autosomal dominant spinocerebellar ataxias (SCA). Among these non-
motor dysfunctions, sleep disorders have been recognized, although still under or even 
misdiagnosed. In this review, we highlight the main sleep disorders related to cerebellar 
ataxias focusing on REM sleep behavior disorder (RBD), restless legs syndrome (RLS), 
periodic limb movement in sleep (PLMS), excessive daytime sleepiness (EDS), insomnia 
and sleep apnea. 
Key words: sleep disorders, ataxias, diagnosis.
Distúrbios do sono nas ataxias cerebelares
RESUMO
As ataxias cerebelares se caracterizam por uma enorme variedade de etiologias, cursando 
tanto com sintomas motores como também com sintomas não motores. Recentemente, 
várias evidências têm demonstrado uma frequência elevada de sintomas não motores 
nas ataxias cerebelares, especialmente nas ataxias espinocerebelares autossômicas 
dominantes (SCA). Dentre os sintomas não motores, estão os distúrbios do sono, que 
muitas vezes são sub-diagnosticados ou pouco valorizados. Nessa revisão, enfatizamos 
os principais distúrbios do sono relatados nas ataxias cerebelares, como transtorno 
comportamental do sono REM, síndrome das pernas inquietas, movimentos periódicos 
das pernas no sono, sonolência diurna excessiva, insônia e apnéia do sono. 
Palavras-chave: distúrbios do sono, ataxias, diagnóstico.
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Cerebellar ataxias comprise a wide 
range of neurodegenerative, congenital, 
mitochondrial, and metabolic diseases 
leading to central nervous system-related 
motor and non-motor dysfunctions1. 
Among these non-motor dysfunctions, 
sleep disorders have been recognized, al-
though still under or even misdiagnosed. 
Their pathogenesis may be secondary to 
direct structural alterations of the sleep-
wake generating cells and networks or be 
the consequence of several indirect mech-
anisms1. Recently, a large body of evidence 
have demonstrated that non-motor man-
ifestations are much more frequent than 
previously thought not only in autosomal 
dominant spinocerebellar ataxias (SCA), 
but also in several other neurodegener-
ative diseases such as synucleinopathies 
(Parkinson’s disease, Lewy body dementia 
and multiple system atrophy), taupathies 
(Alzheimer’s disease, frontotemporal de-
mentia, corticobasal degeneration, pro-
gressive supranuclear palsy), amyotrophic 
lateral sclerosis, and prion diseases1. 
The most frequent recognized sleep 
disorders in patients with neurodegener-
ative diseases are insomnia, hypersomnia, 
parasomnias, excessive nocturnal motor 
activity, circadian sleep-wake rhythm dis-
turbances, respiratory dysrhythmias and 
sleep apnea1. It is crucial to recognize 
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sleep disorders in neurodegenerative diseases not only to 
make an earlier diagnosis, but also to improve the quality 
of life1,2. In this review, we highlight the main sleep disor-
ders related to cerebellar ataxias focusing on REM sleep 
behavior disorder (RBD), restless legs syndrome (RLS), 
periodic leg movement in sleep (PLMS), excessive day-
time sleepiness (EDS), insomnia and sleep apnea1,3.
Sleep disorders in autossomal dominant SCAs 
SCAs have been defined as a group of autosomal 
dominant ataxic disorders caused by degeneration of the 
cerebellum and its afferent and efferent connections. The 
majority of SCA are also complicated by the presence of 
additional neurological signs and non-motor symptoms, 
such as sleep disorders4. Additionally, extra-cerebellar al-
terations vary between genotypes4. 
Sleep complaints, particularly RLS and PLMS, have 
been observed in some forms of SCAs, with a higher 
frequency in SCA1, SCA2, SCA3 or Machado Joseph 
disease (SCA3/MJD), and SCA61,5,6. Available evidence 
shows that the frequency of RLS in SCAs is significantly 
greater than in the general population ranging from 20 
to 30%6. In line with this we describe in the following 
section the most frequent sleep disorders seen mainly 
in SCAs 1,2,3 and 6.
Spinocerebellar ataxia type 1 (SCA1): RLS has 
been poorly reported in patients with SCA 1. Among 
the few data available the frequency of RLS in patients 
with SCA1 is estimated to be 23% in a small sample6. An-
other study showed a similar frequency, but with even 
fewer patients. One study pointed out to a lack of asso-
ciation between RLS and periodic limb movement on 
polysomnography5. Interestingly, one study did not show 
evidence for RLS in SCA1 showing that the frequency 
actually varies according to patient selection or study 
methodology5,6. Recently, EDS and fatigue were also re-
ported in two individuals with SCA1, suggesting that 
EDS in SCA1 may be an inherent consequence of the 
neurodegenerative disorder itself, and wake-promoting 
agents may be of benefit7.
Spinocerebellar ataxia type 2 (SCA2): RLS has been 
described in patients with SCA2, and frequency ranges 
between 18 and 27%5,6. Moreover, two previous studies 
have shown RBD in SCA2 patients characterized with 
REM without atonia and mioclonic jerks8,9. PLMS had a 
higher frequency in just one of the studies9. 
Spinocerebellar ataxia type 3 or Machado Joseph 
disease (SCA3/MJD): SCA3/MJD is the most common 
autosomal dominant-subtype of ataxia worldwide4,10. The 
disease comprises a wide range of clinical manifestations, 
which include cerebellar ataxia, parkinsonism, dystonia, 
peripheral neuropathy, pseudoexophthalmos, lower 
motor neuron disease, with fasciculations and amyot-
rophy10. Recent studies also point out for a more diffuse 
neurodegeneration, which better explains the non-motor 
symptoms of the disease and possibly under-recognized, 
such as sleep disorders, memory deficits and executive 
impairment, olfactory dysfunction and psychiatry dis-
turbances (Table 1)11. In addition, the cerebellum it-
self has also been involved in non-motor functions. Re-
cent clinical data has demonstrated high incidence of 
sleep complaints in SCA3/MJD12. Likewise, sleep com-
plaints have been considered as an important modifier 
of health-related quality of life in SCAs12. The most fre-
quent reported sleep complaints in SCA3/MJD are RLS13, 
RBD14, EDS14, sleep apnea12, and insomnia12. Curiously, 
not only these sleep disorders might be a frequent non-
motor symptom in SCA3/MJD, but may also precede the 
onset of cerebellar symptoms2. 
When we consider SCA3/MJD patients, frequency 
rates of RLS are high, reaching about 55% in several 
studies12,14,15. Regarding the dopaminergic system dys-
function of primary RLS, it is speculated that RLS could 
reflect basal ganglia impairment in patients with SCAs5. 
Also, RBD has a higher frequency in SCA3/MJD patients 
when compared to the general population, reaching up to 
50%12. The underlying involvement of midbrain cholin-
ergic and pontine noradrenergic systems seen in SCA3/
MJD patients could in part explain these higher rates of 
RBD2,3. Likewise synucleinopathies, RBD and RLS may 
precede any other clinical manifestation of cerebellar 
symptons by more than 10 years2.
High frequencies of EDS have been documented in 
SCA3/MJD patients12,14. Furthermore, in some series, 
insomnia was the most frequently reported sleep dis-
order12. There is also a higher frequency of sleep apnea 
in SCA3/MJD than in general population ranging from 
20 to 25%12. Patients who reported snoring and possible 
apnea during sleep had longer disease duration and were 
older12. Moreover, hypnagogic hallucinations are more 
related in SCA3/MJD patients than healthy subjects12. 
Figure describes some polysomnographic features in a 
patient with SCA3/MJD. 
Spinocerebellar ataxia type 6 (SCA6): One study 
found a marked increase in PLMS indices in five patients 
with SCA6. Interestingly, all patients had a normal nerve 
Table 1. Non-motor symptoms of SCA3/MJD patients.
• Sleep disorders
• Psychiatric disorders (depression, anxiety and psychotic 
symptoms)
• Cognitive dysfunction
• Olfactory dysfunction
• Other non-motor symptoms: cramps, chronic pain and fatigue 
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conduction study excluding peripheral neuropathy as a 
cause of their limb complaints. The same study showed 
RLS in two of 5 patients and no RBD16. A larger study 
with 21 SCA6 patients found only one patient with RLS 
and sleep apnea13. 
Table 2 is a brief summary of many studies con-
cerning sleep disorders found in different SCAs subtypes. 
We have not found enough data to inform the frequency 
of sleep disorders in the SCAs other than SCA 1, 2, 3 
and 6, although some sporadic reports are available in 
the literature. 
Sleep disorders in recessive ataxias 
Recessive ataxias may be divided into five groups: 
Congenital, mitochondrial, metabolic, degenerative, and 
related to defects in DNA repair17. A limited number of 
data is available concerning sleep disorders in recessive 
ataxias. 
Among congenital ataxias, Joubert syndrome and 
related disorders (JSRD) are the most remarkable. This 
term is adopted to describe a group of diseases that pres-
ents the “molar tooth sign” in brain imaging. JSRD is 
typically characterized by hypotonia, ataxia, respiratory 
disturbances, and abnormal ocular movements. The 
typical respiratory abnormalities are represented by ep-
isodes of apnea and/or hyperventilation that can range 
since from brief periods of hyperpnea until long attacks 
of apnea18. Although first described in awake state, the 
respiratory abnormality can occur during sleep. It has 
been described a sleep disordered breathing manifesting 
as repetitive tachypnea followed by central apnea, and 
isolated tachypnea during asleep, interestingly detected 
only in non-REM sleep19. 
Friedreich ataxia (FA) is the commonest recessive 
ataxia worldwide, manifesting as progressive sensory 
and cerebellar ataxia, arreflexia, Babinski sign, often as-
sociated with cardiomyopathy, scoliosis and pes cavus17. 
Data on sleep disorders in patients with FA is poor. It 
has been published a case of mixed apnea, with obstruc-
tive and central apnea in one patient with late stage FA20.
A polysomnographic study in twelve patients with 
ataxia telangiectasia, a recessive disease that causes not 
only ataxia, but also cutaneos telangiectases, immunode-
ficiency, sino-pulmonary infections and lymphoreticular 
malignancies, was conducted to evaluate the patterns of 
sleep and respiration during sleep. The authors found 
decreased sleep efficiency when compared to normal 
values, eight patients with obstructive apnea and hy-
popnea, and four with central apnea, approximately half 
of them with oxygen desaturations21. 
Despite the lack of enough previous studies concerning 
sleep disorders in recessive ataxias, we realized that the 
Figure. PSG of a 52 year-old-woman, with clinical and molecular 
diagnosis of SCA3/MJD. This is an epoch of 20 seconds of REM 
sleep showing its typical EEG features and a paradoxically high 
amplitude of the submental muscle, characterizing the phenom-
enon RWA for this interval. Note also PLMS and FM disclosed in 
both legs. PSG: polysomnography; EEG: electroencephalography; 
N3: stage 3 of non-REM sleep accounting for the old stage 3 and 
stage 4 of Rechtchaffen and Kales sleep scoring system; RWA: REM 
without atonia; FM: fragmentary myoclonus; PLMS: periodic leg 
movement in sleep.
Table 2. Frequency of sleep disorders in patients with various types of autosomal dominant cerebellar ataxias.
Sleep disorder SCA 1 SCA 2 SCA 3/MJD SCA 6
RLS 23% (3/13) 18% (2/11) 56.7% (21/37) 23.8% (5/21)
RBD NA 80% (4/5) 45.9% (17/37) NA
EDS NA NA 45.3% (24/53) NA
Insomnia 50% (3/6) 18% (2/11) 37.7% (20/53) 23.8% (5/21)
Nightmares NA NA NA NA
OSA NA NA 22.6% (12/53) NA
PLMS NA NA NA NA
Hypnagogic hallucinations NA NA 38.4% (20/53) NA
SCAs: spinocerebellar ataxias; RLS: restless legs syndrome; RBD: REM sleep behavior disorder; EDS: excessive daytime sleepiness; OSA: obstructive sleep apnea; 
PLMS: periodic leg movement in sleep; NA: not available. Statistical analysis of the table is reported in references 6, 8, 9, and not published information of 
our division of cerebellar ataxias.
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main sleep complaints are related to breathing. There-
fore, physicians should be aware about sleep-breathing 
disorders in recessive ataxias and polysomnography 
study should be promptly performed in this situation.
Sleep disorders in sporadic ataxias
Multiple system atrophy (MSA) is a sporadic neuro-
degenerative disease characterized clinically by various 
combinations of cerebellar, parkinsonism, autonomic and 
pyramidal symptoms or signs. Pathologically is charac-
terized by cell loss, gliosis and glial cytoplasmatic inclu-
sions in several brain and spinal cords structures22. When 
cerebellar ataxia is the dominant clinical feature, the dis-
ease is termed MSA-C. The signs of cerebellar dysfunc-
tion include disorders of extraocular movements, ataxia 
of speech, ataxia of limbs movements and gait22.
MSA patients have multiple sleep-related disorder 
symptoms including EDS, insomnia, arrhythmic respi-
ration, sleep apnea, RBD, and sleep-related stridor with 
vocal cord paresis23. OSA and central sleep apnea fre-
quently occur in MSA and may cause sudden death. RBD 
is closely related to neurodegenerative disorders, spe-
cially the synucleinopathies, and may precede motor 
symptoms of PD or MSA by years24. It has been demon-
strated that REM sleep behavior disorder may precede 
other aspects of synucleinopathies by up to 25 years25. 
Another data comparing sleep disturbances in patients 
with PD, MSA and PSP demonstrated that patients with 
MSA showed higher risk of OSA and less frequent RLS26. 
The PRIAMO study, which analyzed non-motor symp-
toms in atypical and secondary parkinsonism, found that 
sleep disturbances were also common with a prevalence 
of approximately 70% in all diagnostic groups, including 
MSA patients27.
RBD and nocturnal stridor are considered red flags 
and may be the first symptoms of the disease22. Sleep-
disordered breathing manifests as [1] central hypoventi-
lation that reflects impaired automatic control of venti-
lation secondary to degeneration of the pontomedullary 
respiratory centers; and, more commonly, as [2] stridor 
and obstructive sleep apnea due to larynx narrowing sec-
ondary to combined vocal cord abductor paralysis and 
excessive adductor activation during inspiration23. 
The recent identification of fragile X-associated 
tremor ataxia syndrome (FXTAS) associated with pre-
mutations in the FMR1 gene and the possibility of clin-
ical overlap with multiple system atrophy has raised im-
portant questions. These neurodegenerative diseases 
may have similar clinical presentations, including sleep 
disorders28. 
Alexander disease (AD) in its typical form is an infan-
tile lethal leucodystrophy, characterized pathologically 
by Rosenthal fibers accumulation. Detailed clinical and 
genetic data from one study of 11 cases of adult-onset 
AD showed that the most frequent symptoms were re-
lated to bulbar dysfunction with dysarthria, dysphagia, 
dysphonia, pyramidal involvement and cerebellar ataxia. 
Sleep disorders were also observed in four cases29.
Sporadic fatal insomnia is a rare prion disease that 
has recently been recognized and is characterized by 
loss of sleep, oneiric stupor with autonomic/motor hy-
peractivity and somato-motor abnormalities, including 
pyramidal signs, myoclonus, dysarthria, dysphagia and 
ataxia30. In the new variant of Creutzfeldt-Jakob disease 
some patients demonstrated a combination of psychi-
atric symptoms, ataxia and severe sleep disorders31.
Although still unrecognized sleep disorders in cer-
ebellar ataxias have been a recent issue of interest, and 
growing evidence has proving the importance of their 
identification. Not only because sleep disorders in cer-
ebellar ataxias may precede the onset of motor symp-
toms, but also due to its impact in the health-related 
quality of life. 
A similar problem found in the studies aforemen-
tioned is that the numbers of patients already evalu-
ated are too small to conclude specific patterns of sleep 
disorders in a single group of cerebellar ataxias, for in-
stance SCA3, and also limited information on the exact 
frequency of these sleep-complaints limits a full data in-
terpretation. Therefore, future studies addressing sleep 
disorders in a large sample population with cerebellar 
ataxias are welcome. Additionally, a standardized assess-
ment of these patients should be considered to allow data 
comparisons within different research centers. 
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